Image for Jane Xu Kelly

Jane Xu Kelly

Malaria remains one of the deadliest diseases in the world today and accounts for over 200 million clinical cases worldwide each year along with roughly half a million deaths, mostly children under the age of five and pregnant women. With increasing drug resistance and the absence of a clinically available vaccine, there is an urgent need and continuous search for new chemotherapy to combat malaria. Our research projects focus on the drug discovery and development of novel therapeutic agents for prevention and treatment of malaria, thus supporting world-wide elimination of the disease. With local and worldwide collaborations, we study the chemical, molecular, and cellular basis of drug action and drug resistance using multidisciplinary techniques and methods.